SITC 2017 Abstract Titles – Best Practices for Improving Cancer Immunotherapy Treatment Administration and Polypharmacy Management

To search for abstract content based on keywords, select CTRL+F on your keyboard (or Command+F if you're using a Mac) and type a keyword to search for abstracts related to that keyword.







Mapping the treatment pathway for metastatic uveal melanoma (mUM) patients in England: A qualitative pilot study

Elisabeth Adams1, Chih-Yuan Cheng1, Joseph Sacco2, Sarah Danson3, Pippa Corrie4, Paul Nathan5, Peter Szlosarek6, Joanne Upton2, Abolore Amuludun6, Toby Toward7

1Aquarius Population Health Limited, London, United Kingdom 2The Clatterbridge Cancer Centre, Wirral, United Kingdom 3Weston Park Hospital, Sheffield, United Kingdom 4Addenbrooke's Hospital, Cambridge, United Kingdom 5Mount Vernon Cancer Centre, London, United Kingdom 6Barts Cancer Institute, London, United Kingdom 7Immunocore Limited, Abingdon, United Kingdom

Chemotherapy | Checkpoint blockade | Clinical trial | Epidemiology | Immune monitoring | Immune toxicity | Surgery | Solid tumors | Targeted therapy


Continued Challenges and Opportunities in Oncologists’ COMPREHension of Clinical Immunology and its relationship with cancer immunotherapy

Tara Herrmann1, Charlotte Warren1, Haleh Kadkhoda2, Lianne Wiggins3

1Medscape Education Oncology, New York, NY, USA 2Medscape Education, New York, NY, USA 3SITC, Milwaukee, WI, USA

Checkpoint blockade | Solid tumors


PDL-1 status and value for Extrapulmonary small cell carcinomas

Mohammed Salhab1, Yiqin Xiong1, Karen Dresser1, Benjamin Chen1, James Liebmann1

1University of Massachusetts, worcester, MA, USA

Checkpoint blockade | Tumor stroma | Tumor infiltrating lymphocytes (TILs) | Tumor microenvironment